AnaptysBio, Inc. ($ANAB)
Filing Information
| Accession Number | 0001276840-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 8, 2026 |
| Document Date | Jan 6, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
62,798
Total Value
$86,069.88
P&L
+inf% (+$3,143,196.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF FINANCIAL OFFICER | Common Stock | โ | Jan 6, 2026 | Exercise/Conversion | 5,245 | โ | โ | 19,575 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Common Stock | โ | Jan 7, 2026 | Sale | 1,908 | $45.11 | $86,069.88 | 17,667 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Restricted Stock Unit | Derivative | Jan 6, 2026 | Exercise/Conversion | 5,245 | $0.00 | $0.00 | 5,245 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Restricted Stock Unit | Derivative | Jan 6, 2026 | Grant/Award | 21,400 | $0.00 | $0.00 | 21,400 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Stock Option (right to buy) | Derivative | Jan 6, 2026 | Grant/Award | 29,000 | $0.00 | $0.00 | 29,000 | Direct | โ | View Details |